| Quick Answer |
| ㆍIndian guidelines flag obesity much earlier, at a BMI of 23 to 25. Doctors consider both when prescribing. ㆍIndian product labels consider adults with a BMI of 30 or more or 27 or more with a weight-related condition. ㆍGovernment statements in 2026 suggest that endocrinologists and internal medicine specialists, with cardiologists listed for certain indications, are eligible to prescribe GLP-1. An MBBS-only family doctor is not on that list. ㆍExpect HbA1c; you’ll be tested for fasting glucose, a lipid profile, kidney and liver function, thyroid function, and, where relevant, a pregnancy test. ㆍIt usually takes a few days to a week from the first consult to the first dose. |
For most people, a GLP-1 prescription may seem like a singular moment: a doctor signs, and a chemist hands over a pen. In India, the process is a four-part checklist, where each part is governed by its own rule.
You need the right doctor, the right numbers, the right blood tests, and a prescription that a pharmacy will accept. Skip one, and the process either stalls or continues without the safety net it was designed to provide.
The rules became stricter in 2026. After generic versions hit Indian shelves in March, regulators issued new advisories on who can prescribe these medicines and how they can be promoted. Here is what that means for a GLP-1 prescription in India, piece by piece.
Who Qualifies: BMI and Health Criteria
Two sets of numbers determine eligibility, but they don’t always align.
The first is the approved usage printed on the label. India’s drug regulator, CDSCO, has cleared these medicines for weight management in adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, type 2 diabetes, or abnormal cholesterol.
The second is the Indian definition of obesity, which begins much lower.
The 2009 Indian consensus statement set the Indian BMI range that most clinics still quote: 23 marks overweight, 25 marks obesity, and a waist of 90 cm in men or 80 cm in women signals belly fat (abdominal obesity). The 2025 revised definition by Misra and colleagues went further. It treats any BMI above 23 as obesity and splits it into two stages, where stage 2 includes excess belly fat and weight-linked problems such as type 2 diabetes or knee arthritis.
Why draw the lines lower for Indians? A large share of Asians carry a high risk of diabetes and heart disease, and at a BMI below the global cut-off of 25, Indians tend to carry more body fat than Western people, especially in the abdomen.
In Caleyachetty and colleagues’ analysis of 1.47 million adults, South Asians reached the diabetes risk a white adult carries at a BMI of 30, while their BMI was just 23.9. For a woman 160 cm tall, that is about 61 kg.
Most guides oftentimes skip this gap between label and guideline.
Picture a user with a BMI of 26, a 96 cm waist, and a fatty liver. She is clearly obese by Indian standards, yet she sits below the label line unless a qualifying condition is present. When it comes to prescribing outside the label (off-label use), only the treating specialist can decide, and regulators have stressed sticking to approved indications. Expect the doctor to either explain the reasoning clearly or refuse outright.
Indian BMI range and what it means at a GLP-1 consult
| Measure | Indian guideline reading | What it means for a prescription |
|---|---|---|
| BMI 18.5 to 22.9 | Normal | Not a candidate for weight-management prescribing |
| BMI 23 to 24.9 | Obesity (2025); stage 1 | Below the label line, lifestyle care comes first. |
| BMI 25 to 26.9 | Obesity | Below the label line. Any prescription needs a specialist’s judgement. |
| BMI 27 to 29.9 | Obesity | Within the label, if at least one weight-related condition is present |
| BMI 30 and above | Obesity | Within the label |
| Waist 90 cm or more (men), 80 cm or more (women) | Abdominal obesity | Strengthens the clinical case; not a label criterion on its own |
Who Can Prescribe a GLP-1 in India
The list is short, and an MBBS-only family doctor is not on it.
The Health Ministry has only approved GLP-1 medicines on the condition that they are prescribed by endocrinologists and internal medicine specialists. For some indications Cardiologists are also eligible, but in a written reply in the Rajya Sabha in 2026, the Minister of State for Health only mentioned endocrinologists and internal medicine specialists. The point is that these medicines cannot be bought over the counter.
Endocrinologist, physician, telemedicine doctor
Endocrinologist: A hormone and metabolism specialist, usually with a DM or DNB in endocrinology after an MD. This is the natural first stop if you are already diagnosed with diabetes, a thyroid disorder, or PCOS. A search for ‘endocrinologist near me’ will give you plenty of names, but check the degree before the star rating.
Physician: On an Indian clinic board, ‘physician’ usually means an MD in internal medicine, not a general practitioner. That difference matters here. An MD medicine specialist is on the government’s list; an MBBS doctor without that postgraduate training is not.
Telemedicine doctor. Not necessarily a separate category. In fact, it is the same as an endocrinologist, internist, or cardiologist. The only difference is that the consultation takes place over video. A search for ‘weight loss doctor near me’ often returns apps rather than people, so look for the name behind the platform, their qualifications, and their medical council registration number.
The Consultation: What the Doctor Checks
Your first consultation will feel less like a sales pitch and more like an audit of your health history. Expect your weight, height, waist, and blood pressure to be measured, after which the doctor works through your story.
What the doctor asks, and why
| Topic | What the doctor is looking for |
|---|---|
| Weight history | How long the weight has been there, what you have tried, and whether it returns after every diet |
| Existing conditions | Diabetes, thyroid disorders, PCOS, sleep apnea, fatty liver, gallstones, past pancreatitis, kidney disease |
| Family history | Medullary thyroid cancer, or a rare inherited condition called MEN2 (multiple endocrine neoplasia type 2) |
| Current medicines | Insulin and sulphonylurea tablets, which raise the risk of low sugar when combined with a GLP-1 |
| Pregnancy plans | These medicines are stopped before trying to conceive. |
| Eating patterns | A typical day of meals, and any past history of disordered eating |
A significant chunk of your consultation will focus on your food history. What you eat in a day helps the doctor make informed decisions. A person who consumes three cups of sweet chai, two katoris of rice at lunch, and late-night namkeen tells the doctor about where their appetite pressure sits and what the medicine will be working against.
A thorough consult also covers the downsides of these medications, namely, nausea in the early weeks, slower digestion, and a briefing over what to do if vomiting stops you from keeping fluids down. If side effects are not mentioned, that silence is worth noticing.
Blood Tests Before Starting
Most specialists order a baseline panel before the first dose. It catches anything that changes the plan and gives you a ‘before’ picture to compare against later.
Because Indians tend to develop high blood sugar at lower body weights, it’s not rare for people to arrive at a weight consultation with prediabetes or diabetes they never knew they had.
The usual baseline panel
| Test | What it tells the doctor |
|---|---|
| HbA1c and fasting glucose | Whether you have diabetes or prediabetes, which changes the dose plan and how closely you are monitored |
| Lipid profile | Cholesterol and triglycerides, a core part of heart risk |
| Kidney function (creatinine, eGFR) | A baseline, because repeated vomiting or diarrhea can dehydrate the kidneys. |
| Liver function | A baseline, and often the first hint of fatty liver |
| Thyroid function (TSH) | An underactive thyroid can drive weight gain and needs its own treatment. |
| Pregnancy test | For women who could be pregnant, before the first dose |
| Extras when indicated | Pancreatic enzymes, vitamin B12, or others, only if your history points there |
Please note that a TSH test does not screen for the rare thyroid cancer. That risk is assessed through your family history.
Preparation for the blood test is simple. Fast for 8 to 10 hours overnight. Water is fine, but hold on to the morning chai until after the sample. Ask the doctor whether to take your usual morning medicines first and carry any reports from the last three months, since some tests may not need repeating.
Who Should Not Take a GLP-1
Some people are ruled out outright while others require closer monitoring. Anyone with a personal or family history of medullary thyroid cancer or MEN2, anyone pregnant or breastfeeding, and anyone who has had a serious allergic reaction to these medicines are immediately ruled out. Children and teenagers fall outside the adult weight-management approvals discussed here, and people with type 1 diabetes cannot use them in place of insulin.
If you have had a past episode of pancreatitis, gallstones, severe stomach-emptying problems (gastroparesis), kidney disease, diabetic eye disease, or a history of an eating disorder, you are required to proceed with caution. Users on insulin or sulfonylureas often need those doses lowered to avoid low sugar.
The Health Ministry has publicly listed many serious risks of using GLP-1 while having the above-mentioned ailments; it leads to pancreatitis, kidney injury, and bowel obstruction, alongside common effects such as nausea.
If you are scheduled for surgery, it is important to inform your surgeon or anesthesiologist that you are on GLP-1 because slower stomach emptying matters before sedation.
None of these issues are any reason for alarm. However, this is why the law insists on a specialist’s consult.
Legal Rules: Prescriptions and Telemedicine
Behind every legitimate GLP-1 prescription in India, there are three main rules to be aware of.
The drug law: Under the Drugs and Cosmetics Act 1940 and its Rules, GLP-1 are prescription-only medicines. A pharmacy may dispense them only against a valid prescription from a registered medical practitioner.
The regulator’s conditions: Beyond the prescriber list, CDSCO issued an advisory against surrogate advertising and indirect promotion of these medicines and asked state drug controllers to tighten watch over the supply chain. That is why you will not see them advertised and why a reputable clinic talks about eligibility rather than products.
The telemedicine rules: The Telemedicine Practice Guidelines 2020 allow registered doctors to consult and prescribe remotely. They form part of the medical ethics regulations overseen by the National Medical Commission (NMC), which replaced the Medical Council of India.
Additionally, keep in mind the following non-negotiable guidelines: The doctor must state their name and qualification; their registration number must be on the prescription, your identity should be confirmed, anonymous consultations are not allowed, and you should receive a signed or digital prescription.
Medicines are also sorted into lists by how they may be prescribed remotely. Some may be prescribed in their first video consult; others only at follow-up after an in-person visit. GLP-1 medicines are not named in any list, so the safer reading is to first video consult and get a full assessment, then go for an in-person visit if the doctor finds anything unclear.
A prescription that arrives bundled with a purchase, after a questionnaire and no real conversation, does not meet this standard. If in doubt, you can check your doctor’s registration on the NMC’s Indian Medical Register.
Needles at home: Clinics follow the Bio-Medical Waste Management Rules 2016, which send used needles into puncture-proof containers for proper treatment. At home, the practical equivalent is a hard plastic bottle with a screw cap, handed back to your clinic or pharmacy if they accept sharps. Loose needles never go in the kitchen dustbin.
Timeline: From First Consult to First Dose
The whole process usually takes a few days to a week. The table below will show the typical path; yours will depend on your reports and on what they show.
A typical path to the first dose
| Step | Typical timing | What happens |
|---|---|---|
| First consultation | Day 1 | History, measurements, eligibility discussion, tests ordered |
| Blood tests | Day 1 or 2 | Fasting sample at a lab or through home collection |
| Reports | Day 2 or 3 | Routine results usually arrive within 24 to 48 hours. |
| Review and prescription | Days 3 to 7 | The doctor reads the results, confirms eligibility, and writes the prescription. |
| First dose | At or soon after review | Usually with a demonstration of the pen or injection |
| Dose steps | Every four weeks or so | The dose rises gradually so the stomach can adjust. |
A high HbA1c that requires diabetes treatment before starting GLP-1, an abnormal thyroid result, or plans for pregnancy will slow your path to your first dose. None of these are failures, but required checks before treatment.
Documents to Keep
Keeping a folder of all your documents from day one, either on paper or on your phone, speeds up follow-ups and protects you if something goes wrong.
Your GLP-1 paperwork
| Document | Why it matters |
|---|---|
| Prescription | Shows the doctor’s name, qualification, registration number, date, and dose plan; the pharmacy will require this every time. |
| Baseline lab reports | Your ‘before’ picture; repeat tests are read against them. |
| Pharmacy bill with batch number and expiry | Needed if you ever report a reaction or a quality problem |
| Weekly dose log | Date, dose, and injection site; useful when the dose steps up. |
| Side-effect notes | What happened, when, and for how long makes follow-ups precise. |
| Monthly waist and weight record | Shows change in belly fat that the scale alone can miss |
Any suspected reactions can be reported to the Pharmacovigilance Programme of India, run by the Indian Pharmacopoeia Commission, which has been asked to track adverse events linked to these medicines.
| Conclusion |
| A GLP-1 prescription in India rests on four things: a BMI read against both the label and Indian thresholds, a qualified specialist, a baseline blood panel, and a prescription that meets the drug and telemedicine rules. When each piece is in place, treatment starts safely. If you miss even one of these requirements, that gap serves as a warning. |
Frequently Asked Questions
1. What BMI qualifies me for GLP-1 treatment in India?
Indian product labels consider adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as type 2 diabetes, high blood pressure, or abnormal cholesterol as qualified. Indian guidelines flag obesity risk from a BMI of 23 to 25, with a waist above 90 cm in men or 80 cm in women. A specialist weighs both before deciding.
2. Which specialist can prescribe a GLP-1?
Government statements in 2026 name endocrinologists and internal medicine specialists, with cardiologists also listed for certain indications. These specialists can prescribe in person or through a video consult under the Telemedicine Practice Guidelines 2020, provided the prescription carries their medical council registration number.
3. What blood tests are needed before starting?
A typical baseline panel covers HbA1c and fasting glucose, a lipid profile, kidney and liver function, and thyroid function (TSH). Women who could be pregnant usually take a pregnancy test. Extra tests, such as pancreatic enzymes, and vitamin B12 are added only when your history points to them. Fast for 8 to 10 hours before the sample.
4. Can a general physician prescribe these medicines?
An MBBS-only general practitioner is not on the government’s stated list of prescribers. On Indian clinic boards, ‘physician’ often means an MD in internal medicine, and they can prescribe. Check the qualification printed on the prescription before you take it to a pharmacy.
5. How long does it take from consultation to first dose?
Usually a few days to a week. The first consult and blood tests often happen within a day or two, reports return within 48 hours, and the doctor reviews them before writing the prescription. Abnormal sugar or thyroid results, or plans for pregnancy, can add time.
| Medical Disclaimer |
| This article is for general education and is not medical advice. GLP-1 medicines are prescription-only in India and must be used under the supervision of a qualified specialist. Do not start, stop, or change any medicine without speaking to your doctor. If you have severe abdominal pain, persistent vomiting, or signs of an allergic reaction, seek medical care promptly. |